Please login to the form below

Not currently logged in
Email:
Password:

Apogee files two US patent applications for intradermal delivery system

Apogee Technology has filed two US provisional patent applications relating to its intradermal drug delivery technology 

US-headquartered biotech Apogee Technology has filed two US provisional patent applications relating to its intradermal drug delivery technology.  

The new patent applications describe advanced macromolecular formulations and coating methodologies.

Dr Alexander K Andrianov, Apogee's vice-president of R&D, said, "These filings are an important achievement of the company's ongoing research and development programme and are intended to protect rights for formulations with improved coating efficiency, methods and systems for precise dose control."

23rd July 2007

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Clark Health Communications

Clark Health Communications (CHC) is an independent, award-winning health and medical communications agency. Our collaboration with experts and advocates enhances...

Latest intelligence

ema1
The European Medicines Agency: PRIME’d for access?
Leela Barham examines the impact of the EMA's PRIME fast track system after two years...
How can pharma engage with key stakeholders on NHS service transformation?
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare consulting team, explain how pharma should make its case for change...
michael elliot
The race for an HIV ‘cure’
Supercharging therapies as pharma and patients work together...

Infographics